Brief: Grifols' Biotest Launches Immunodeficiencies Medicine Yimmugo In U.S.
09/10/2025 16:38
Oct 9 (Reuters) - Grifols SA GRLS.MC: GRIFOL'S UNIT BIOTEST LAUNCHES YIMMUGO IN THE UNITED STATES Source text Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Grifols
See all newsSpanish stocks - Factors to watch on Nov 3
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail